Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials
- 22 November 2005
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 19 (12), 2139-2142
- https://doi.org/10.1038/sj.leu.2403854
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93Leukemia, 2003
- Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working partyLeukemia, 2002
- Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93Leukemia, 2001
- Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trialLeukemia, 1999
- Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78Blood, 1985